{"timestamp": 1771604731.4480956, "value": {"ticker": "VTGN", "company_name": "Vistagen Therapeutics, Inc.", "short_name": "VistaGen Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 22971860, "float_shares": 33777509, "shares_outstanding": 39620317, "short_ratio": 1.46, "short_percent_of_float": 0.0736, "shares_short": 2036211, "shares_short_prior": 3385220, "insider_percent_held": 0.0026800002, "institution_percent_held": 0.34868, "total_cash": 61770000, "total_debt": 1427000, "total_revenue": 789000, "revenue_growth": 0.295, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -64.508255, "debt_to_equity": 2.802, "current_ratio": 4.675, "book_value": 1.285, "price_to_book": 0.45120624, "operating_cashflow": -60298000, "free_cashflow": -36167000, "price": 0.5798, "52w_high": 5.14, "52w_low": 0.43, "avg_volume": 2886850, "avg_volume_10d": 1307000, "full_time_employees": 59, "audit_risk": 0, "overall_risk": 0}}